The proportion of ownership interest in an associate attributable to the entity. [Refer: Associates [member]]

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 27
-IssueDate 2017-01-01
-Paragraph 17
-Subparagraph b
-Clause iii
-URI http://eifrs.ifrs.org/eifrs/XBRL?type=IAS&num=27&date=2017-03-01&anchor=para_17_b_iii&doctype=Standard
-URIDate 2017-03-09

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 27
-IssueDate 2017-01-01
-Paragraph 16
-Subparagraph b
-Clause iii
-URI http://eifrs.ifrs.org/eifrs/XBRL?type=IAS&num=27&date=2017-03-01&anchor=para_16_b_iii&doctype=Standard
-URIDate 2017-03-09

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 12
-IssueDate 2017-01-01
-Paragraph 21
-Subparagraph a
-Clause iv
-URI http://eifrs.ifrs.org/eifrs/XBRL?type=IFRS&num=12&date=2017-03-01&anchor=para_21_a_iv&doctype=Standard
-URIDate 2017-03-09

Name:	ifrs-full_ProportionOfOwnershipInterestInAssociate
Namespace Prefix:	ifrs-full_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

Events after the reporting period - Additional Information (Detail) - AUD ($)	Oct. 31, 2018	Jul. 31, 2018
Anti tropomyosin program [member] \| TroBio Therapeutics Proprietary Limited [Member]
Disclosure of non-adjusting events after reporting period [line items]
Equity interest, percentage		12.00%
Subsequent Event [Member] \| Share purchase plan [Member]
Disclosure of non-adjusting events after reporting period [line items]
Share placement amount	$ 3,400,000
Share purchase plan maturity date	Nov. 16, 2018
Subsequent Event [Member] \| Share purchase plan [Member] \| Top of range [member]
Disclosure of non-adjusting events after reporting period [line items]
Share placement eligibility ownership capacity amount	$ 15,000